Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Aggregation and Inflammation Markers in Ischemic Stroke After Fibrinolytic/Anti-Thrombotic Use
NCT05415150Phase 2Unknown
- Sponsor
- Baylor College of Medicine
- Start
- Feb 2022
- Primary completion
- Aug 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eptifibatide in ischemic stroke, sponsored by Baylor College of Medicine. Status: unknown.
02
Drugs
eptifibatide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05415150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05415150.